Brazil and Russia to co-operate on irradiation centres

6 December 2016

Russia’s United Corporation for Innovations (UIC), a subsidiary of state nuclear corporation Rosatom, and Brazilian company CK3 on 1 December signed a memorandum of understanding for the development, construction and operation of an Irradiation Centre in Brazil. The memorandum establishes cooperation between the parties and involves coordinating efforts to implement and operate projects for irradiation centres in Brazil, using technologies based on the use of electron accelerators for sterilisation of pharmaceuticals, cosmetics and healthcare products, among others applications. The project benefit from Russia’s competences and achievements in the radiation technology field, and Brazil’s local knowledge of the market.

"We see great potential in the Brazilian market in the field of medical products sterilization by means of irradiation technologies. The use of irradiation technologies in the Brazilian health area can significantly improve the safety and quality of goods and services. Hermetically packaged medical products can be effectively sterilized, which reduces the risk of contamination in the production phase. Products treated with the radiation sterilisation method will also increase the export potential of Brazilian companies engaged in the production of medical goods", said UIC director general Denis Cherednichenko.

He stressed that Russia was offering a turnkey project. "We do not only create a project and equip the irradiation centre, but also train employees and provide services. Our approach is the ultimate focus on the customer.”

CK3’s director for investor relations, Rodrigo Cherkezian, noted: “We have been studying the irradiation market for some time, and despite its global relevance, there has been little investment in our country. The potentials of this sector led to our investment decision to diversify our portfolio.” 



Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.